Product Images Imatinib Mesylate

This is a medication description for Imatinib Mesylate Tablets, manufactured by Apotex Corp. Each tablet contains 1105 mg of matnib mosylato (equivalent 10 100 mg of imaini). It is recommended to store in a tight container at 20°C to 25°C (68°F to 7T°F). It also indicates "Gantolled Room Temperature" and to "Protect from Moisture." The usual dosage and instructions for use are included in the package insert. The product comes in a 90-tablet package with the NDC reference 60505-2900-9.*

Each tablet contains 478 mg of masnib mosylats, which is equivalent to 400 mg of imainb. These tablets should be stored between 20°C to 25°C (86°F to 77°F), but excursions are permitted from 15°C to 30°C (80°F to 85°F). They must be protected from moisture and should be dispensed in the provided container. The usual dosage is mentioned on the package insert. This product is manufactured by Apotex Corp. and is called Cammaa LT Imatinib B Mesylate Tablets 400 mg.*

This appears to be a table or graph showing the efficacy of Imatinib Mesylate and IFN4ARAC in treating patients with progression to AP or BC. The graph shows the number of patients, censored patients, and the ratio of those on the Imatinib Mesylate arm versus the IFN+Ara-CArm. The Log-rank Test was significant with a value of Pa0.001. The x-axis headers show months since randomization.*